4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-031641
Director acquired 600,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ultragenyx Pharmaceutical Inc. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-05-20 | Exercise or conversion : show line 1 in the form | +600,000 | $16.00 | $9,600,000 | 3,000,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-05-20 | Exercise or conversion : show line 2 in the form Option (Right to Buy) | −600,000 | 0 | D |
Loading xslF345X03/doc4.xml…